Karl Deisseroth
Biotech

How Nobel-winning optogenetics is being harnessed by biotechs

Fierce spoke to Nobel Prize winner Karl Deisseroth, M.D., Ph.D., and other optogenetics pioneers to discover how this science could benefit patients.
Darren Incorvaia Oct 9, 2026 9:30am
shutterstock25078614631png

There Is No Such Thing as a Typical Biotech

Brought to you by Syneos Health
GSK

GSK drinks in Chai’s AI models after wet-lab validation

Oct 9, 2026 10:36am
How to Choose a Biologics CDMO 4 Criteria That Matter the Most

4 Criteria for Choosing the Right Biologics CDMO

Brought to you by Rezon Bio
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Vir looks to Liu to lead late-stage push—Chutes & Ladders

Oct 9, 2026 8:30am
Podcast
Fierce 15

How we picked the Fierce 15

Oct 9, 2026 7:21am
More News

TRex rakes in $117M IPO, while Retension reveals $45M listing

Oct 9, 2026 4:29am

Endeavor Hedgehog inhibitor has potential to shake up IPF space

Oct 8, 2026 9:50am

Iambic aims for $135M IPO to push cancer drugs through clinic

Oct 8, 2026 8:45am

‘It’s just survival’: Why a third of Boston lab space sits empty

Oct 8, 2026 8:00am